Info

The Psychedelic Podcast

The Psychedelic Podcast connects you to the leaders and pioneers of the psychedelic renaissance. From deep healing to creativity, leadership to spirituality, business, health, human performance, relationships, sexuality, and even culture itself—every aspect of our world is being transformed by psychedelic medicines. Get an inspired, informed, balanced look into how these powerful medicines are already being safely and responsibly used to catalyze both personal and collective transformation. Whether you’re just curious or a seasoned psychonaut, or somewhere in between, you’ll get insightful, practical, cutting-edge conversations from the forefront of the psychedelic movement. Join us as we explore how psychedelics can be integrated into culture for the evolution of humanity.
RSS Feed Subscribe in Apple Podcasts
The Psychedelic Podcast
2024
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
October
September
August
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
August
July
June
May
April
March
February
January


All Episodes
Archives
Now displaying: Page 2
Aug 28, 2023

In this Psychedelic Podcast episode, Paul F. Austin welcomes Phoebe McPherson to discuss the resurgence of kanna, a legal psychoactive plant, in the global market.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-210-phoebe-mcpherson

Paul and Phoebe explore kanna’s rich South African history, heart-opening qualities, and recent revival in the wellness space. Their comprehensive discussion asks questions like: How does kanna compare to MDMA? What led Phoebe to explore kanna, and how did it change her life? How can this plant help regulate the nervous system? Can you stack kanna extract with psychedelics like psilocybin and LSD? What does a kanna microdosing protocol look like?

Paul and Phoebe uncover everything you need to know about starting a kanna protocol, safe product sourcing, and ingestion tips.

Phoebe McPherson:

Phoebe McPherson is an educator, herbalist, gatherer, and the Head of Brand & Education at Fungtion, a nature-inspired wellness brand on a mission to help people reconnect to their bodies and nature through mushroom and plant formulas. Phoebe has spent years working with and learning from experts in the field about the healing aspects of nature’s gifts. While she is deeply knowledgeable about medicinal mushrooms, psychedelics, and plants, her passion lies in sharing kanna (Sceletium tortuosum) with the world, helping others find safety in their first steps to connect with nature.

Highlights:

  • Understanding kanna benefits and traditional usage.
  • Phoebe’s journey to kanna during pivotal shifts in her life.
  • Kanna vs. MDMA: How do they compare?
  • The story of kanna’s re-emergence in the world market.
  • Uncovering kanna’s clinical potential.
  • Combining kanna with other substances.
  • Exploring kanna as an adaptogen with psychedelic qualities.
  • Kanna supply and sustainability questions.
  • How to safely source and ingest kanna.
  • Kanna’s subjective benefits and personal healing stories.
  • How to connect with Phoebe.

Key Links:

Episode Sponsors:

Aug 21, 2023

In this Psychedelic Podcast episode, Paul F. Austin welcomes Jonathan Sabbagh, CEO of Journey Clinical, who shares his mission to integrate FDA-approved psychedelics within the modern therapeutic framework.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-209-jonathan-sabbagh/

Jonathan highlights the disjointed nature of today’s mental health system, where therapists and prescribers lack communication, hindering comprehensive assessments and referrals. He and Paul emphasize Journey Clinical’s collaborative care model, streamlining information exchange, and maximizing psychedelic-therapy access through telemedicine innovation. They explore Journey’s potential challenges of scalability, therapist training, and insurance coverage for extended sessions. And they consider the balance between state-level decriminalization, psychedelic medicalization, and decentralized access.

Join Paul and Jonathan as they imagine a new mental healthcare infrastructure that addresses the growing crisis and reinvents therapeutic care as we know it.

 

Jonathan Sabbagh:

Jonathan Sabbagh is the Co-Founder and CEO of Journey Clinical, the leading telehealth platform expanding access to psychedelic-assisted psychotherapy. A serial entrepreneur, Jonathan built his career in finance, spending over two decades working for hedge funds and building businesses in Switzerland and NYC.

After receiving a difficult diagnosis of PTSD and extreme burnout, Jonathan left the world of finance to focus on his mental health. During that time, he personally experienced the transformative benefits of plant medicine and ketamine-assisted psychotherapy (KAP). Jonathan’s healing journey inspired him to begin formal clinical psychology training at the New School, with the vision of expanding access to transformative psychedelic-assisted therapies to the millions of Americans with depression and anxiety.

Jonathan’s personal and professional journey motivated him to found Journey Clinical in 2020, the #1 platform in the US that enables licensed mental health professionals to deliver KAP at scale.

Highlights:

  • How Jonathan’s mental health & finance background led him to start Journey Clinical.
  • Jonathan’s take on co-founding and running Journey Clinical with his wife.
  • The origin story of Journey Clinical and its startup challenges.
  • Exploring Journey’s collaborative care model.
  • Investigating Journey’s infrastructure solution for psychedelic-assisted therapy.
  • Journey’s vetting requirements for network therapists.
  • How the Ryan Haight Act might affect ketamine telehealth access.
  • Journey’s decentralized approach to safe and responsible ketamine telemedicine.
  • Integrating FDA-approved psychedelics into the mainstream mental health infrastructure.
  • Jonathan’s long-term vision for collaborative mental health care through Journey Clinical.

Key Links:

Episode Sponsors:

Aug 14, 2023

In this Psychedelic Podcast episode, Paul F. Austin meets meditation teacher and healer Spring Washam at the MAPS Psychedelic Science Conference to discuss Buddhism, psychedelics, and ancestral wisdom.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-208-spring-washam

Paul and Spring delve deep into the synergies and incompatibilities across healing modalities. They ask whether indoor practices can ever rival nature’s transformative power. They reflect on innate desires toward rooting on land and the consequences of disconnection. They ask whether the spirit of Harriet Tubman and other ancestral heroes can heal society’s conflicts. And they explore the psychedelic divide between Southern traditions and Northern adaptations.

Join Paul and Spring for a fascinating perspective on mindfulness, plant medicine, and the evolution of society.

Spring Washam:

Considered a pioneer in bringing mindfulness-based meditation to diverse communities; Spring Washam is a well-known teacher, healer, and visionary leader based in Oakland, California.

She is the author of A Fierce Heart: Finding Strength, Courage and Wisdom in Any Moment and The Spirit of Harriet Tubman: Awakening from the Underground.

Spring is one of the founding teachers at the East Bay Meditation Center, an organization that offers Buddhist teachings with attention to social action and multiculturalism. She is a member of the teachers’ council at Spirit Rock Meditation Center, offering teachings on Buddhist philosophy, Insight meditation, and loving-kindness practices. Spring is also the founder of Lotus Vine Journeys, a one-of-a-kind organization that blends indigenous healing practices with Buddhist wisdom in transformative retreats in Central America.

She has practiced and studied Buddhist philosophy in both the Theravada and Tibetan schools of Buddhism since 1999. Spring is also a shamanic practitioner, studying indigenous healing practices since 2008.

Spring’s workshops, interviews, and writing can be found in mainstream media worldwide.

Highlights:

  • How Buddhist practitioners view psychedelics.
  • Spring’s early ayahuasca journeys and revelations.
  • Spring’s lessons from Buddhist lineages.
  • Jack Kornfield’s guidance and teachings.
  • Spring’s Lotus Vine Journeys ayahuasca retreats in Costa Rica.
  • How psychedelics and Buddhism reconnect us to nature.
  • Spring’s journey from California to Georgia to start a plant-medicine community.
  • Exploring the importance of healing human disconnection from the land.
  • Spring’s insights from her book, The Spirit of Harriet Tubman: Awakening from the Underground.
  • Spring’s presentation at the MAPS Conference on Buddhism & ayahuasca.
  • Reflecting on how to bridge modern spirituality with indigenous lineages.

Key Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Continue the conversation about this episode in Third Wave Community. Create your account for free at community.thethirdwave.co

Episode Sponsors:

Aug 7, 2023

In this episode of the Psychedelic Podcast, Paul F. Austin welcomes Christian Angermayer, a serial entrepreneur and investor in psychedelics, longevity, fintech, crypto, and future tech.

Get full show notes, links, and transcript here: https://thethirdwave.co/podcast/episode-207-christian-angermayer/

Christian is a notable figure in the field of psychedelic medicine, both respected and controversial. He has been a driving force in pushing psilocybin toward FDA-approval. But his company atai Life Science's psychedelic patents have drawn criticism from decriminalization-first advocates. Some wonder if the medical approach to psychedelics conflicts with the idea of open access and shamanic usage. Christian delves into this question, examining opposing views and exploring other dichotomies, such as whether capitalism and spirituality can coexist in the realm of psychedelics. He also considers the potential conflict between the search for psychedelic wisdom and the desire for immortality.

Christian’s conversation with Paul presents a new perspective on psychedelics, exploring nuanced topics and questioning the future of psychedelic biotech, microdosing, and longevity science.

Christian Angermayer:

Christian Angermayer is a serial entrepreneur and investor who builds and invests in companies that are shaping the Next Human Agenda: a future in which technology empowers people to live longer, healthier, and happier lives.

Christian’s family office and private investment firm, Apeiron Investment Group, has more than USD 2.5 billion under management and 50 people across five international locations. Apeiron focuses on Life Sciences, FinTech & Crypto, Future Tech and Experiences, and Hospitality & Happiness. Over the past 20 years, Christian has founded three unicorns and has been the lead investor in four unicorns and two decacorns.

Christian is the world’s largest investor in psychedelics and is recognized for leading the current psychedelics renaissance. He founded atai Life Sciences, investigating the potential of psychedelic compounds including psilocybin, ketamine, DMT, and ibogaine as approved medical treatments.

Highlights:

  • Exploring psychedelics and the evolution of organized religion.
  • The parallels between ancient psychedelic traditions and modern medicalization.
  • An argument for democratizing psychedelic access through centralization.
  • Christian’s thoughts on creating a regulated framework for microdosing.
  • Optimism about longevity research and extended lifespans.
  • Overcoming deeply-rooted fears and embracing the concept of a long life.
  • Christian’s challenges and successes at COMPASS Pathways & atai Life Sciences.
  • The obstacles of commercializing psychedelic medicines in an economic downturn.
  • Investigating how psychedelics might contribute to longevity.
  • How psychedelics can help us find and live our Dharma (life’s purpose).

Key Links:

Apeiron Investment Group: https://apeiron-investments.com/

atai Life Sciences: https://atai.life/

COMPASS Pathways: https://compasspathways.com/

Episode Sponsors:

Jul 31, 2023

In this episode of the Psychedelic Podcast, Paul F. Austin welcomes Dr. Sarah Abedi to share her journey from conventional emergency medicine to psychedelic healing and advocacy.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-206-sarah-abedi-md/

Dr. Abedi discusses the need for a paradigm shift in modern healthcare, incorporating indigenous and integrative modalities to create a holistic healing approach. She highlights TREAT California, a citizen-led ballot initiative aimed at funding an expansive psychedelic ecosystem with $5 billion. Dr. Abedi explores the initiative’s focus on research, education, access, and treatment, emphasizing its potential to bring psychedelic healing into the mainstream zeitgeist.

This thoughtful conversation delves into the distinctions between Western medicine and psychedelic wisdom, envisioning a new healthcare model that bridges the gap and guarantees access for all.

Sarah Abedi, M.D.:

Sarah Abedi, M.D. is an emergency medicine physician and facilitator of psychedelic clinical research trials.

She is the Chief Medical Officer and Advocacy and Impact Officer for TREAT California, an initiative aimed at creating a $5B funding agency in the state to support research, education, training, and access. As a psychedelic facilitator, Dr. Abedi is also part of Pacific Brain Health’s Treatment & Research In Psychedelics Program (TRIP). She has completed training at the Center for Psychedelic Therapies and Research at California Institute of Integral Studies (CIIS) and is certified as a Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-Assisted Therapist. Dr. Abedi is the co-founder of the integrative mental health institute Onea.

Highlights:

  • Dr. Abedi’s journey from conventional medicine to psychedelic healing.
  • The TREAT California ballot initiative.
  • TREAT Initiative's path to holistic healthcare in California.
  • Dr. Abedi’s experience as a facilitator of psilocybin clinical trials.
  • The opportunity to bridge old institutions with new psychedelic paradigms.
  • Nature’s role in modern healing.
  • Exploring low-dose psychedelics for healing & spirituality.
  • Dr. Abedi’s work with TREAT.
  • Envisioning an integrated psychedelic healthcare model.
  • Dr. Abedi’s desire to do healing work in her homeland of Iran.
  • How to connect with Dr. Abedi.

Key Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode Sponsors:

Jul 24, 2023

In this episode of the Psychedelic Podcast, Paul F. Austin reunites with renowned author Steven Kotler to dive deep into the realms of peak performance aging and flow states.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-205-steven-kotler/

Kotler's latest book, Gnar Country: Growing Old, Staying Rad takes center stage as they explore the profound impact of continuous learning, experiences in nature, and adventurous pursuits throughout life. With Kotler's expertise in human performance, the conversation uncovers the secrets to maintaining optimal mental states and staying active in later life.

Listeners will embark on a thought-provoking journey into the possibilities of thriving in aging as Steven decodes the neurobiology of flow.

Steven Kotler:

Steven Kotler is a New York Times bestselling author, award-winning journalist, and the Executive Director of the Flow Research Collective. He is one of the world’s leading experts on human performance.

Steven is the author of eleven bestsellers out of fourteen books, including The Art of Impossible, The Future is Faster Than You Think, Stealing Fire (part of the curriculum in the Psychedelic Coaching Institute’s Coaching Certification Program), The Rise of Superman, Bold, and Abundance. His work has been nominated for two Pulitzer Prizes, translated into over 50 languages, and has appeared in over 100 publications, including the New York Times Magazine, Wired, Atlantic Monthly, Wall Street Journal, TIME, and the Harvard Business Review.

Alongside his wife, author Joy Nicholson, he is also the co-founder of The Buddy Sue Hospice Home for Old Dogs, a canine elder care facility, and Rancho de Chihuahua, a dog rescue and sanctuary.

Highlights:

  • Steven’s motivation to write his newest book on peak performance aging, Gnar Country.
  • Steven’s favorite adult development models related to healthy aging.
  • Decoding the neurobiology of flow and establishing a solid scientific foundation.
  • Examining flow from ancient Eastern and Western philosophical perspectives.
  • Steven’s reflections on bringing flow into corporate environments.
  • Why older employees could be the dream workforce of the 21st century.
  • Steven’s flow principles of aging successfully & maintaining cognitive function.
  • Exploring the surprising benefits of action sports for peak performance aging.
  • Skills cultivation, nature experiences, & the importance of “leisure activities” in old age.

Key Links:

Episode Sponsor:

Jul 17, 2023

In this episode of the Psychedelic Podcast, Paul F. Austin welcomes Jaiya, somatic sexologist and creator of the Erotic Blueprint Breakthrough™.

Find episode links, summary, and transcript here.

Jaiya shares the extensive experience and research that led to the creation of the Erotic Blueprint, a framework that helps individuals discover and express their authentic erotic selves. The conversation explores the five Erotic Blueprints–Energetic, Sensual, Kinky, Sexual, and Shapeshifter–highlighting their unique qualities and shadow aspects. The conversation emphasizes that sexual expression, compatibility, and consciousness are learnable skills anyone can cultivate. 

As the episode unfolds, Paul and Jaiya explore ecstatic states while drawing parallels between sexuality and psychedelics as inherent life forces.

Jaiya:

Internationally recognized, award-winning sexologist and best-selling author (Red Hot Touch and Cuffed, Tied & Satisfied), Jaiya is the creator of the Erotic Blueprint Breakthrough™ and the Erotic Blueprint™ Quiz. Through more than two decades of client observation and clinical research, she discovered a map of arousal that reveals your specific erotic language of turn-on. This revolutionary framework helps you create deeper connections and total sexual satisfaction.

Highlights:

  • The five Erotic Blueprints and their unique sexual expressions.
  • Jaiya’s journey to becoming a somatic sexologist.
  • The role psychedelics played in Jaiya’s healing, transformation, and sexuality.
  • Psychedelics for healing sexual trauma and facilitating full sexual expression.
  • The importance of safe containers and consent when it comes to sex and psychedelics.
  • Cultivating ecstatic literacy.
  • Finding cosmic union through Tantra.
  • The Erotic Blueprint coaching certification program.
  • What Jaiya is working on next.

Key Links:

Episode Sponsor:

Jul 10, 2023

Dr. Evan Cole Lewis, VP of Psychedelic Neurology at Numinus, joins The Psychedelic Podcast to delve into the world of psychedelic neurology and its potential to revolutionize medicine.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-203-evan-cole-lewis-md/

Dr. Lewis & Paul F. Austin take us deeper into the underlying mechanisms of psychedelics and their impact on neurological networks. The conversation explores how psychedelics like MDMA, ketamine, psilocybin, and LSD can manipulate and reorganize those networks, leading to tailored treatment approaches for people with neurological conditions. From Dr. Lewis’s perspective, precision psychedelic medicine is poised to provide breakthrough treatments for traumatic brain injuries, concussions, functional seizures, cluster headaches, migraines, and mental illnesses.

With cautious optimism, Dr. Lewis and Paul envision a future where psychedelics offer transformative solutions for today’s most challenging conditions.

Evan Cole Lewis, M.D.:

Dr. Evan Cole Lewis is a neurologist and clinical neurophysiologist with expertise in pediatric neurology and epilepsy. He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto.

Dr. Lewis is the founder and medical director of the Neurology Centre of Toronto (NCT), Chief Medical Advisor for the Jamaican Medical Cannabis Corporation and VP of Psychedelic Neurology at Numinus, a Canadian company focused on research and therapeutics with psychedelic medicines.

Dr. Lewis has extensive clinical experience in the utilization of medical cannabis for the treatment of neurologic conditions in both adults and children. His practice focuses on brain network disorders, including concussion/persistent post-concussive symptoms, headache and migraine, and functional seizures.

He has a special interest in treating brain network disorders with psychedelic therapy. He has delivered many national and international educational seminars, talks, and lectures on brain network disorders, medical cannabis, psychedelic therapy, and the intersection of psychedelics and neurology.

Highlights:

  • Why Dr. Lewis chose to work at Numinus.
  • Exploring how psychedelics bridge the gap between psychiatry and neurology.
  • Why psychedelics challenge neurology to adopt a complex-systems approach.
  • How psychedelics counterbalance neural rigidity with harmony & flexibility.
  • Psychedelics’ potential to treat traumatic brain injuries (TBIs).
  • Ketamine’s role in activating & strengthening dormant neural pathways.
  • How plant medicine helps people unlearn old habits & experience child-like awareness.
  • The mystery of functional seizures.
  • Dr. Lewis’ belief that psychedelics will enhance neuroscience & precision medicine.

Key Links:

Episode Sponsor:

Jul 3, 2023

Scott Omelianuk, Editor-in-Chief of Inc. Business Media, joins the Psychedelic Podcast to examine the intersection of entrepreneurship, mental health, and psychedelics.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-202-scott-omelianuk/

Scott and Paul F. Austin emphasize the importance of supporting founders' mental well-being and how psychedelics can play a role in reducing stress and enhancing mindfulness. Scott openly shares his personal struggles, revealing the profound impact of psychedelic therapy that surpassed years of talk therapy. By embracing mental health challenges, Scott believes leaders can overcome pressures, uncertainties, and isolation, enabling them to become their best selves.

The conversation envisions psychedelics as tools to foster human connection and long-term thinking, ultimately cultivating a more conscious and compassionate mindset among entrepreneurs.

Scott Omelianuk:

Scott Omelianuk is the Editor-in-Chief of Inc. Business Media. He has built a reputation for defining culture and using it to the advantage of clients and benefit of consumers.

Honored with the Ad Age A-List, Idea of the Year award, and a Media Vanguard Award, Scott is known as a marketing and branding expert and champion of entrepreneurial thinking within the enterprise and small business.

A professor of marketing and innovation and an entrepreneur-in-residence at the Stevens Institute of Technology, a U.S. News & World Report “Top 25 Innovation School,” Scott has repositioned Inc., the preeminent voice of entrepreneurship, to reflect the needs of today’s founder, with inspiration, information, and instruction, as well as community.

As an author, investor, founder, and patent holder, Scott has been profiled or served as an expert source for the New York Times, the Wall Street Journal, Ad Age, AdWeek, CNN, the BBC, NHK, NPR, CNBC, MSNBC and dozens of other newspapers, blogs, and broadcast outlets around the world.

Highlights:

  • Scott’s personal drive to explore psychedelics.
  • Inc.’s reason for writing about leadership struggles & mental health issues.
  • Lessons psychedelics can teach business leaders.
  • Scott’s professional path to becoming Editor-in-Chief at Inc.
  • The challenges of maintaining a long-term vision in a capitalist world.
  • Scott’s reflection on the state of the psychedelic renaissance.
  • The importance of keeping a beginner’s mind in the early stages of the movement.
  • Scott’s take on microdosing vs. macrodosing.
  • Scott’s personal and professional outlook.

Key Links:

Episode Sponsors:

Jun 26, 2023

Professor Russell A. Berman joins the Psychedelic Podcast to explore the captivating life and works of controversial German writer Ernst Jünger.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-201-russell-a-berman-phd/

Jünger’s initial career as a German officer shaped his early books examining war and politics. After the war, Jünger continued writing prolifically, exploring genres like science fiction and nature. He remained a contentious figure due to his conservative and military background. However, in his later years, Jünger became interested in drugs and altered states of consciousness. His book “Approaches,” later edited by Professor Berman, serves as an autobiography through the lens of his experiences with mind-expanding substances.

As the episode unfolds, Professor Berman and Paul F. Austin unpack the book “Approaches” and Jünger's psychedelic perspectives.

Russell A. Berman is the Walter A. Haas Professor in the Humanities at Stanford and Senior Fellow at the Hoover Institution, where he co-directs the Working Group on the Middle East and the Islamic World.

He formerly served as Senior Advisor on the Policy Planning Staff of the United States Department of State, focusing on transatlantic relations, and as a member of the Commission on Inalienable Rights. He is also a member of the National Humanities Council.

Berman has been awarded a Mellon Faculty Fellowship at Harvard and an Alexander von Humboldt Fellowship for research in Berlin. He has also been honored with the Federal Service Cross of the Federal Republic of Germany. His books include The Rise of the Modern German Novel: Crisis and Charisma and Enlightenment or Empire: Colonial Discourse in German Culture—both of which won the Outstanding Book Award of the German Studies Association.

He has edited several translations of works by Ernst Jünger and Carl Schmitt.

Highlights:

  • Dr. Berman frames Jünger’s life; world wars, political activism, and literary works.
  • Professor Berman reflects on the history of drug culture.
  • Jünger’s writings on psychedelics, including LSD, psilocybin, mescaline, and more.
  • How altered states impacted Jünger’s religious life and philosophy.
  • Jünger’s relationship with Albert Hofmann, the man who first synthesized LSD.
  • Examining Jünger, Hofmann, Timothy Leary, & Richard Alpert’s (Ram Dass) shared history and psychedelics perspectives.
  • Jünger’s nuanced place in German political history.
  • Why Dr. Berman is fascinated with Jünger’s life and writings.
  • Dr. Berman reads selections from Junger’s book Approaches.

Links:

These show links contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode Sponsors:

Jun 19, 2023

In this episode of the Psychedelic Podcast, clinical counselor Salimeh Tabrizi, M.A. and Paul F. Austin examine ayahuasca, cannabis, and the concept of non-duality.

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-200-salimeh-tabrizi

Salimeh shares her wisdom on the importance of reverence, consciousness, and compassionate witnessing when working with powerful plant medicines. She delves into different ayahuasca lineages and traditions, uncovering valuable insights into their transformative potential. She also explores the delicate balance between masculine and feminine energies, the importance of holistic healing, and the significance of self-care in cultivating Buddha nature.

This conversation invites listeners to explore non-dual tools for integrating plant medicine teachings into life’s spiritual journey.

Salimeh Tabrizi, M.A. is a clinical counselor, intuitive energy worker, and plant medicine facilitator, educator and advocate. She supports individuals before, during, and after sacred medicine journeys with Ayahuasca as they step into their soul path and mission. Salimeh is a founding board member of the Canadian Psychedelic Association and the founder and organizer of the Cannabis Hemp Conference and Expo, the largest plant medicine conference in Canada from 2015-2018. She is inspired by the co-evolutionary process between humans and entheogenic plants such as Ayahuasca, Cannabis, Psilocybin, Iboga and San Pedro.

Highlights:

  • Salimeh’s first Ayahuasca experience with the Yawanawa in the Amazon.
  • Exploring different Ayahuasca lineages, from indigenous to neo-shamanistic.
  • What Ayahuasca has taught Salimeh about non-duality.
  • The importance of being a compassionate witness to psychedelic journeys.
  • Why integrating psychedelics is so difficult.
  • Salimeh’s components of enlightenment and awakening.
  • Ayahuasca & Cannabis: Do they mix?
  • Emphasizing reverence, consciousness & love in working with cannabis.

Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode Sponsors:

Jun 12, 2023

Cory and Jay Fiset, a married couple with extensive entrepreneurial experience, join Paul F. Austin to share their psychedelic path to marriage reinvention. 

Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-199-cory-jay-fiset/

The Fisets believe intentional psychedelic use fostered a deep connection that reignited their passion and commitment after years of drifting apart. Psilocybin and MDMA journeys allowed them to be witnessed and heard as their true selves in profoundly healing ways. By letting go of blame and taking personal accountability, the Fisets experienced a shift from co-dependency to self-realization. Cory and Jay now help couples discover self-expression and devotion through their “Connection Experience” psychedelic couples retreats.

Cory & Jay Fiset:

Cory and Jay Fiset are a husband-and-wife team who have been in relationship for 37 years. After 25 years of marriage, they reinvented themselves and their relationship through intentional use of psychedelic medicine. Together, they offer intentional, safe, and intimacy-enhancing medicine experiences to committed couples who want to discover, express, and connect with themselves and each other.

Cory and Jay are Certified Psychedelic Guides who focus on supporting couples. Their work draws upon 30+ years of facilitating intense personal development programs, individual coaching, experiential workshops, and couples retreats.

Highlights:

Cory and Jay’s relationship story.
The slow drift apart that called for a couples intervention.
Cory and Jay celebrate their 25th anniversary with MDMA.
How psychedelics impacted Cory and Jay’s entrepreneurial lives.
How the Connection Experience couples retreat was born.
The power of MDMA in couples therapy.
How to connect with Jay & Cory.

Key Links:

The Connection Experience: https://theconnectionexperience.love
Jay & Cory’s Facebook Page: “Love Sex and Psychedelics”: https://www.facebook.com/groups/1304760743238728/
Connection Experience “Fireside Chat” Q&A video: https://theconnectionexperience.love/fireside 

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode Sponsors:

CURED Nutrition's Serenity Gummies. Get 15% off by using coupon code “THIRDWAVE” at checkout. http://www.curednutrition.com/thirdwave 

Jun 5, 2023

Psychedelic scientist Manesh Girn joins Paul F. Austin to reveal the impact of psychedelics on the brain as a whole.

Find episode links, summary, and transcript here.

Manesh Girn is in the latter stages of obtaining his Ph.D. in Neuroscience at McGill University and has been the lead or co-author on over a dozen scientific publications and book chapters on topics including psychedelics and the default mode network. 

He is currently researching the brain mechanisms underlying psychedelic drugs in collaboration with Dr. Robin Carhart-Harris and other leaders in psychedelic science. As a postdoctoral psychedelic neuroscientist, he will join Dr. Carhart-Harris at UCSF in August 2023. Manesh is also Chief Research Officer at the Canadian psychedelic bioscience company EntheoTech Bioscience. He runs a YouTube channel and Instagram page called The Psychedelic Scientist, where he discusses the latest research in an easy-to-understand but non-superficial form.

Girn advocates for a personalized approach to psychedelic research that considers individual brain characteristics, mental health conditions, and environment in order to truly understand their effects. He challenges the misconception that psychedelics are inherently beneficial and highlights the importance of positive inputs for positive outcomes. This compelling conversation further explores the influence of set and setting, the interdisciplinary nature of psychedelics, and their potential to shape self-identity.

Manesh and Paul F. Austin uncover profound insights into the neuroscience of psychedelics and the need for personalized, comprehensive research.

Episode Sponsors:

 

May 29, 2023
Jeffrey Stevens, co-founder and CEO of Psyched Wellness, joins The Psychedelic Podcast to discuss Calm, North America's first legal supplement derived from Amanita muscaria.

Find episode links, summary, and transcript here.

Amanita muscaria mushrooms’ red-and-white speckled caps are emoji-level iconic. But most people don’t know that consuming low dosages can reduce stress levels, promote relaxation, and offer a restful sleep without next-day grogginess. Amanita extracts also possess anti-inflammatory properties that could significantly relieve pain. And that’s just the tip of the iceberg, according to Stevens.

As the episode unfolds, Stevens imagines the future of Amanita research for mental health, addiction, and insomnia, while revealing his life-changing experience as a Psyched Wellness guinea pig.

Jeffrey Stevens has 20+ years of capital markets’ experience and has been an officer and director with several public companies. He has taken three companies public via reverse takeover, built teams, and structured multiple M&A transactions, while building successful businesses.

Highlights:

  • The path to Psyched Wellness.
  • Why Psyched Wellness utilizes an Amanita extract vs. the whole mushroom.
  • Amanita muscaria history and lore.
  • Exploring the science of Amanita muscaria and Psyched Wellness’s “Calm” extract, AME-1.
  • Calm’s dose-dependent effects and benefits.
  • Anecdotal evidence on Amanita muscaria for sleep, gut health, and addiction.
  • Calm’s market advantage as a legal food supplement.
  • Jeffrey’s vision for Psyched Wellness’s future.
  • How Psyched Wellness is educating consumers about Amanita muscaria.

Key Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode Sponsors:

Psyched Wellness - use code THIRDWAVE23 to get 15% off.

Third Wave's Mushroom Grow Kit

May 22, 2023

Graham Pechenik, founder and patent attorney at Calyx Law, joins The Psychedelic Podcast to delve into the complex world of patents and their impact on the psychedelic landscape. 

Find episode links, summary, and transcript here.

Pechenik raises thought-provoking questions about the patent system's role in fostering innovation while also potentially hindering research and restricting use. He suggests that the patent system, intertwined with regulatory and healthcare structures, often determines whether groundbreaking substances like psilocybin gain FDA approval. Pechenik also explores concerns surrounding excessive psychedelic patents, comparing the unique approaches of COMPASS Pathways, MAPS, and Paul Stamets. 

As the episode unfolds, Graham and Paul contemplate the delicate balance between patent protection and freedom of use in the burgeoning psychedelics industry.

Graham Pechenik is a registered patent attorney and the founder of Calyx Law, a law firm specializing in cannabis and psychedelics-related intellectual property. 

Graham has a BS from UC San Diego, where he chose Cognitive Neuroscience and Biochemistry majors—after his first psychedelic experiences inspired a deep curiosity about the bases for changes in consciousness—and a JD from New York University, where he initially pursued interests in bioethics and cognitive liberty. 

After a decade at large law firms defending and challenging patents for Fortune 500 companies across the agricultural, chemical, pharmaceutical, biotech, and technology industries, including working on several landmark patent cases both at trial and on appeal, Graham started Calyx Law in 2016 to help cannabis and psychedelics ventures design and implement their IP strategies. 

Graham is also editor-at-large of Psychedelic Alpha, where he writes about psychedelics IP, provides data for patent trackers, and maintains a psychedelics legalization and decriminalization tracker. He is the founding steward of the IP Committee of the Psychedelic Bar Association, where he is also on the Board of Directors, and is a member of Chacruna’s Council for the Protection of Sacred Plants. 

Graham was raised in Oakland, CA, and currently lives in San Francisco.

Highlights:

  • Examining the unique patent process for the Stamets Stack microdosing protocol.
  • How to enforce patents on illegal substances like psilocybin.
  • Unpacking COMPASS Pathways’ psilocybin polymorph patent.
  • The pros & cons of psychedelic patents.
  • How psychedelic patents could hinder therapeutic expansion.
  • Graham’s motivation to enter the psychedelic patents space.

Key Links:

Episode Sponsors:

May 15, 2023

In this episode of The Psychedelic Podcast, Dr. Daniel Stickler and Paul F. Austin explore the cutting-edge field of longevity and precision-performance medicine.

Find episode links, summary, and transcript here.

After over a decade as a general surgeon, Dr. Stickler abandoned modern medicine’s reductionist approach and forged a new path toward holistic health and optimization. He believes that addressing deficiency mindsets and focusing on purpose, love, and community can help people move beyond simply existing and truly thrive. Through his work, Dr. Stickler has discovered ways to reverse biological aging and help people achieve enhanced states of being.

Dr. Stickler shares his insights on how humans can live a life of excellence, the revolutionary field of gene-editing technology, and his transformative psychedelic experiences.

Dr. Daniel L. Stickler is the Co-Founder and Chief Medical Officer at Apeiron ZOH Inc. He is the pioneer behind systems-based, precision-performance medicine, a new paradigm that re-defines medicine from the old symptoms-based disease model to limitless peak performance and systems science in all aspects of life.

Highlights:

  • The need for complex systems-thinking in modern medicine.
  • Dr. Stickler’s psychedelic experiences.
  • Why practitioners must assess patients before psychedelic therapy.
  • Exploring consciousness as a critical aspect of well-being.
  • What science knows about how to reverse biological aging.
  • Actionable daily steps to slow down aging.
  • Dr. Sticker’s personal approach to healthy lifestyles and relationships.
  • Neurohacker Collective and Qualia nootropics for optimal brain health.

Key Links:

Episode Sponsors:

May 8, 2023

Payton Nyquvest, Founder of Numinus ketamine clinics, joins The Psychedelic Podcast to discuss psychedelic industry missteps, opportunities, & the future of communal healing.

Find episode links, summary, and transcript here.

Embracing disruptions and learning from failures are essential in the trailblazing space of psychedelics.

Encouraging industry resiliency, Payton Nyquvest, Founder, Chair, & CEO of Numinus, joins Paul F. Austin to discuss how to conquer setbacks on the path to revolutionizing mental health. Payton believes successful psychedelic leaders must adapt to real-world needs, embrace challenges, and gain conscious insights from direct experiences. Only then can innovators and practitioners create a lasting impact on the world.

Payton Nyquvest is the Founder, Chair, & Chief Executive Officer of Numinus, which empowers people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based, psychedelic-assisted therapies. He has a deep understanding of the psychedelic industry from its infancy, driven by life-saving personal experiences with multiple modalities.

At Numinus, Payton guides strategy, innovation, research, and expansion. He also supports marketing and capital-markets functions.

Highlights:

  • How Numinus aligns psychedelic therapy with real-world needs.
  • Numinus’s three-year journey from inception.
  • Numinus’s experiential training and intuitive drug development.
  • Exploring whether psychedelic therapists need first-hand experience.
  • Payton’s take on conscious leadership in psychedelic-informed business models.
  • Numinus’s collaboration with East Forest.
  • Payton’s vision for Numinus clinics and practitioner training.

Key Links:

Episode Sponsors:

May 1, 2023

Dr. Reid Robison, Chief Clinical Officer at Numinus, joins Paul F. Austin to discuss psychedelic research, legislation, & complementary modalities.

Find episode links, summary, and transcript here.

Dr. Robison shares the challenges and innovations in psychedelic therapy, drawing from his own clinical research and current projects at Numinus, a mental health company that brings safe, evidence-based psychedelic-assisted therapies to people in need.
Explore topics such as the efficacy of psychedelic-assisted therapies, the pros and cons of psychedelic patents, and the need for multimodal approaches to mental health care.

Dr. Reid Robison is a board-certified psychiatrist and Chief Clinical Officer at Numinus, where he oversees clinical services, including teaching and training in ketamine-assisted psychotherapy, for the company's clinics across the US and Canada. He has led over 200 clinical trials in neuropsychiatry and previously served as coordinating investigator for the MAPS-sponsored MDMA-assisted psychotherapy study of eating disorders.

Dr. Robison is currently principal investigator for a number of psychedelic medicine studies with psilocybin, LSD, and DMT. As a researcher and early adopter of ketamine in psychiatry, Dr. Robison got his first grant to study that medicine in 2011, around which time he also led a pivotal IV ketamine study for treatment-resistant depression.

To date, Dr. Robison has guided thousands of ketamine therapy journeys and Spravato dosing sessions, and has also worked in ayahuasca retreat settings abroad. Dr. Robison is an adjunct professor at both the University of Utah and Brigham Young University, and board chair of the Psychedelic Institute, focused on education and research.

Highlights:

  • Dr. Robison's journey into the world of psychedelics, from ketamine research to psilocybin advocacy on Capitol Hill.
  • How patents can expand access to psychedelic therapy through health insurance.
  • Dr. Robison’s innovative studies and projects at Numinus.
  • The need for a new standard of mental health care and the role of complementary modalities in achieving it.
  • Exploring modalities complementary to psychedelic therapy.
  • The promise of personalized mental health care.
  • The pioneering efforts of Numinus in offering employee psychedelic mental health care via ketamine. 
  • The future of insurance and the potential for greater coverage of ketamine-assisted psychotherapy.
  • What’s on the horizon at Numinus.

Key Links:

Episode Sponsors:

Apr 26, 2023

Dr. Anja Loizaga-Velder, Co-Founder of Nierika, joins Paul F. Austin to explore the therapeutic nature of Ayahuasca & other plant medicines.

Find episode links, summary, and transcript here.

This intimate in-person interview was recorded at Dr. Anja’s plant medicine retreat center in Mexico, just after Paul concluded his own 6-day Ayahuasca experience. Topics covered include: mental health from an indigenous perspective, Dr. Anja’s journey bridging Western medicine with traditional healing practices, and the current environmental and political struggles of indigenous healers in Mexico.

Dr. Anja Loizaga-Velder received her master’s degree in psychology (Dipl.-Psych.) from Koblenz-Landau University, Germany, and her doctorate in medical psychology (Dr.sc.hum.) from Heidelberg University, Germany. She is a psychotherapist specializing in humanistic and transpersonal psychology, the study of consciousness, music therapy, and ethnopsychotherapy.

Anja wrote both her master’s thesis and her doctoral thesis on the use of Ayahuasca for the treatment of addictions. She has published several articles in international academic journals and contributed book chapters on the topics of traditional medicine and mental health. She has been invited to exhibit her work in multiple international conferences. She is the Co-Founder of Nierika A.C. and director of psychotherapy and research at the Institute of Intercultural Medicine Nierika A.C. In addition, she is a professor and researcher in the postgraduate course in Medical and Health Sciences at the National Autonomous University of Mexico.

Highlights:

  • The story of Nierika.
  • The indigenous paradigm of healing and mental health.
  • Dr. Anja’s work with and research into therapeutic effects of plant medicine.
  • The political and environmental struggles of the Yaqui tribe and other indigenous healers in Mexico.
  • Dr. Anja’s advice to professionals seeking psychedelic therapy training.
  • Guiding principles for ethically working with plant medicine.
  • The therapeutic effects of Ayahuasca.

Key Links:

Episode Sponsors:

 

Apr 17, 2023

Paul F. Austin is joined by writer/historian/philosopher Jules Evans to explore the need for ecstatic literacy in the third wave of psychedelics.

Find episode links, summary, and transcript here.

Through sharing research, philosophy, and his own work, Jules invites a thoughtful examination of both sides of psychedelics—the light and the shadow. He points to the need for more awareness and research of challenging psychedelic experiences and offers a roadmap to improved ecstatic literacy in today’s culture.

Jules Evans is the director of the Challenging Psychedelic Experiences Project, the author of three books (Philosophy for Life and Other Dangerous Situations; The Art of Losing Control; Holiday from the Self) and the co-editor of Breaking Open: Finding a Way Through Spiritual Emergency. He is an honorary research fellow at the Centre for the History of the Emotions at Queen Mary, University of London.

Highlights:

  • The need for a balance between stoicism and ecstatic experience.
  • Inspirations from Aldous Huxley & other literary heroes.
  • Integrating psychedelics into an “ecstatically naive” Western culture.
  • Jules’s research on challenging psychedelic experiences.
  • The dark side of ketamine: risks of dependency and harm in a booming industry.
  • How culture can improve its ecstatic literacy.

Key Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode Sponsors:

Apr 10, 2023

Jonathan Lu & Shauheen Etminan, founders of Magi Ancestral Supplements, join Paul F. Austin to discuss the rich world of beta-Carbolines.

Find episode links, summary, and transcript here.

Jonathan & Shauheen are the co-founders of VCENNA, a drug discovery company that creates mental wellness solutions from psychoactive plants used ceremonially in Ancestral Eastern traditions. In this enchanting conversation, they share about their research and experimentation into Syrian rue and other near-forgotten plants, unpacking their rich historical and anthropological contexts. They explain the unique neurobiological and subjective effects of beta-Carbolines, including when combined with tryptamine-containing substances such as in an Ayahuasca brew. Paul F. Austin shares his own experiences with their formulation, Stard Deep Meditation Supplement.

Visit ancestralmagi.com to learn more, and use code PAUL10 at checkout for 10% off their unique products.

Highlights:

  • Jonathan & Shauheen’s ventures, VCENNA and Ancestral Magi.
  • Exploring forgotten divine potions, haoma, and soma, and the ancient and modern uses of Espand (Syrian rue).
  • Psychedelics, Buddhism, and meditation.
  • Exploring the physiological effects of beta-Carbolines.
  • Shauheen and Jonathan’s personal experiences with beta-Carbolines and psychedelics.

Key Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode Sponsors:

  • This podcast is brought to you by Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.

Apr 3, 2023

Paul F. Austin welcomes JW Ross, founder & CEO of Botanic Tonics, to discuss his kava-kratom-based alcohol alternative, Feel Free.

Find episode links, summary, and transcript here.

JW Ross is a lifelong innovator and inventor of Botanic Tonic’s “Feel Free” plant-based tonic. He started his career as a Texas oilman who experienced immense corporate success that was tainted with alcohol addiction. After hitting rock bottom and going to rehab, JW purged alcohol from his life and completely pivoted his career. He went on life-changing trips to the South Pacific and Southeast Asia, where he discovered botanical medicines whose ingredients have been used for centuries socially and for wellness. After discovering these plants, JW dedicated his life to finding an herbal solution that would replace alcohol and still give him a euphoric lift with positive impact. He home-tested many concoctions, finally finding the perfect recipe, which turned into the Feel Free tonic recipe.

  • Enjoy $40 off your order of Feel Free: Use the code 3WAVE at checkout.

Highlights:

  • JW’s struggle with alcohol addiction, which led him on a search for alternative social lubricants.
  • How alcohol is an “outlier” among other ancient forms of social lubricants around the world.
  • Feel Free vs. alcohol.
  • Feel Free vs. cannabis.
  • Understanding kratom: types, processing, and effects.
  • Are kava and kratom addictive?
  • JW’s current research and legislative efforts with kava and kratom.
  • Kava tolerance, and JW’s thoughts on alcohol- vs. kava-drinking societies.
  • JW on sourcing ingredients and his vision for Botanic Tonics.

Key Links:

Episode Sponsors:

  • This episode is brought you by Psyched Wellness, creators of Calm, an over-the-counter Amanita Muscaria extract that may help to reduce stress, ease muscular tension and promote restorative sleep. Go to shop.psyched-wellness.com and use code THIRDWAVE23 to get 15% off.
  • This episode is sponsored by Beckley Retreats, a leading holistic wellbeing company that offers transformative self-development programs by leveraging the science-backed power of psychedelics in concert with supportive therapeutic modalities. As a trusted partner of Third Wave, we strongly recommend the upcoming retreats for Beckley in Jamaica, as well as many other locations. Head to go.beckleyretreats.com/thirdwave to book your transformational psilocybin program today.
Mar 27, 2023

Paul F. Austin sits down with Dr. Alexander Shester to discuss his new book, Visionary Healing: Psychedelic Medicine & Shamanism.

Find episode links, summary, and transcript here.

In this intimate, in-person conversation, Alex humbly shares his wisdom and perspective from decades of experience as a psychiatrist and visionary psychedelic explorer. He sheds light on the intersection of shamanism, psychedelics, and mental health, and recalls captivating stories from his time being mentored by the late psychologist and psychedelic researcher Ralph Metzner.

Alexander Shester, M.D. is a medical doctor, board-certified psychiatrist, and Jungian Analyst. He has over thirty years of experience studying and participating in guided Vision Quests using shamanic principles in nature settings. His recently-published book, Visionary Healing: Psychedelic Medicine and Shamanism, is his personal first-hand memoir of using entheogens including ayahuasca, jurema, psilocybin, San Pedro cactus, peyote, iboga, toad, and more, for deep spiritual exploration and his own healing journey.

Highlights:

  • On visionary art and the power of psychedelic plant medicines.
  • Ayahuasca and the transpersonal journey into the collective unconscious.
  • Alex recalls his primary mentor, Ralph Metzner: his visionary circles and contributions to the
  • psychedelic renaissance.
  • The value of community in Alexander’s healing.
  • Alex’s paths to psychiatry and psychedelics.
  • How Alex’s psychedelic experiences informed his psychiatry practice.
  • What can shamanism offer to the field of psychiatry?
  • Remembering our nature-relatedness with the aid of plant medicines.
  • Endarkenment: facing the shadow.
  • Alex’s sage advice for those seeking psychedelic experiences.

Episode Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

Episode sponsors:

This episode is brought you by Psyched Wellness, creators of Calm, an over-the-counter Amanita muscaria extract that may help to reduce stress, ease muscular tension and promote restorative sleep. Go to shop.psyched-wellness.com and use code THIRDWAVE23 to get 15% off.

This episode is sponsored by Beckley Retreats, a leading holistic wellbeing company that offers transformative self-development programs by leveraging the science-backed power of psychedelics in concert with supportive therapeutic modalities. As a trusted partner of Third Wave, we strongly recommend the upcoming retreats for Beckley in Jamaica, as well as many other locations. Head to go.beckleyretreats.com/thirdwave to book your transformational psilocybin program today.

This podcast is brought to you by Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.

Mar 20, 2023

Anna Yusim, M.D., author of Fulfilled, joins Paul F. Austin for a conversation on the intersection of science, spirituality, and psychedelics.

Find episode links, summary, and transcript here.

Dr. Anna Yusim is a Board-Certified, Stanford- and Yale-educated Psychiatrist & Executive Coach with a private practice in New York City and Connecticut.  She is the best-selling author of Fulfilled: How the Science of Spirituality Can Help You Live a Happier, More Meaningful Life.  On the clinical faculty at Yale Medical School, Dr. Yusim is presently creating a Spirituality & Mental Health Center there.  With clients including Forbes 500 CEOs, Olympic athletes, A-list actors and actresses, and the Chairs of academic departments at top universities, Dr. Anna Yusim has helped over 2,000 people in 60 countries achieve greater impact, purpose, and joy in their life and work.

As a highly sought-after speaker, Dr. Yusim gives keynotes for physicians and professionals worldwide on topics related to mental health and spirituality, thriving post-COVID, preventing burnout, meaning-making, and resilience.  For healthcare professionals, corporate leaders, and community members, she also conducts workshops to empower individuals to sharpen their intuition, cultivate authenticity, awaken self-compassion, enhance their capacity for empathy, and improve their ability to connect with others.

Connect with Dr. Yusim at www.annayusim.com or at @annayusim on Instagram, LinkedIn, Twitter, and Facebook.

Highlights:

  • Dr. Yusim’s research on stress with Dr. Robert Sapolsky at Stanford.
  • How Dr. Yusim’s relationship to stress has shifted throughout her life and career.
  • Dr. Yusim’s path to founding the Spirituality & Mental Health Center at Yale.
  • Does psychedelic therapy always need to have a spiritual component?
  • Dr. Yusim explains her book, Fulfilled.
  • Psychic vs. psychotic: schizophrenia, channeling, and shamanism.
  • Dr. Yusim’s forthcoming book on the science of miracles.
  • Making your unconscious conscious to find freedom, choice, and healing.
  • Dr. Yusim’s executive coaching work.

Episode Links:

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

This episode is sponsored by:

Beckley Retreats, a leading holistic wellbeing company that offers transformative self-development programs by leveraging the science-backed power of psychedelics in concert with supportive therapeutic modalities. As a trusted partner of Third Wave, we strongly recommend the upcoming retreats for Beckley in Jamaica, as well as many other locations. Head to go.beckleyretreats.com/thirdwave to book your transformational psilocybin program today.

Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.

Mar 13, 2023

Paul F. Austin is joined by Alex Atwood, Founder & CEO of GravyWork to talk plant medicine, transformational coaching, & more.

Find episode links, summary, and transcript here.

Alex Atwood is a multifaceted, purpose-driven leader with more than 20 years of experience as a serial entrepreneur who helmed four startups in the hospitality and staffing space. He’s also a coach in the emerging psychedelics field, with a focus on optimizing human potential. Alex is a podcaster, public speaker, angel investor in firms that help build a better world, and philanthropist with a soft spot for owners and operators of family businesses.

Alex is working towards an ICF certification in organizational well-being. He has been a coach for Landmark Worldwide, a personal and professional development company, and elevation leader for 1heart. He has led workshops on integrity and self-actualization with the goal of helping attendees realize their own potential and find greater self-esteem, fulfillment, creativity, and productivity.

Highlights:

  • Alex’s transformational ayahuasca experience at 1heart.
  • How Landmark impacted Alex’s trajectory.
  • The ineffable wisdom of plant medicine.
  • Alex’s experience in Third Wave’s Coaching Certification Program.
  • Integrating insights from psychedelics into business and daily life.
  • Alex’s exciting projects on the horizon.

Key Links:

This episode is sponsored by: 

  • Beckley Retreats, a leading holistic wellbeing company that offers transformative self-development programs by leveraging the science-backed power of psychedelics in concert with supportive therapeutic modalities. Head to go.beckleyretreats.com/thirdwave to book your transformational psilocybin program today.

  • Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

  • Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.
1 « Previous 1 2 3 4 5 6 7 Next » 10